AI tool offers more accurate detection of immune-related adverse events in cancer patients
While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related adverse events (irAEs) — side effects that can impact almost every organ in the body to varying degrees. The frequency and severity of irAEs in real-world datasets are not well understood, making it difficult to combine cases effectively across institutions and gain insights into the optimal management of these patients. Since current approaches to investigate irAEs are done manually and are inefficient, researchers from Mass General Brigham have incorporated the use of a prebuilt large language ...













